GUGGENHEIM CAPITAL LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2022$263,000
-11.4%
18,715
-9.7%
0.00%0.0%
Q1 2022$297,000
+4.6%
20,722
-0.4%
0.00%
+100.0%
Q4 2021$284,000
-24.7%
20,807
-9.7%
0.00%
-50.0%
Q3 2021$377,000
+7.1%
23,031
+10.2%
0.00%0.0%
Q2 2021$352,000
+87.2%
20,900
+98.4%
0.00%
+100.0%
Q3 2020$188,000
-10.9%
10,534
-10.4%
0.00%
-50.0%
Q2 2020$211,000
-11.0%
11,763
-24.6%
0.00%0.0%
Q1 2020$237,000
-10.9%
15,609
+15.8%
0.00%0.0%
Q4 2019$266,000
+29.1%
13,482
+12.5%
0.00%0.0%
Q3 2019$206,00011,9860.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders